Home  »  Global Markets Direct

Global Markets Direct Market Research Reports

Thesan Pharmaceuticals Inc - Product Pipeline Review - 2014
Global Markets Direct’s, ‘Thesan Pharmaceuticals, Inc. - Product Pipeline Review - 2014’, provides an overview of the Thesan Pharmaceuticals, Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Thesan Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $1500
Arromax Pharmatech, Co. Ltd. - Product Pipeline Review - 2014
Global Markets Direct’s, ‘Arromax Pharmatech, Co. Ltd. - Product Pipeline Review - 2014’, provides an overview of the Arromax Pharmatech, Co. Ltd.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Arromax Pharmatech, Co. Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $1500
Collegium Pharmaceutical, Inc. - Product Pipeline Review - 2014
Global Markets Direct’s, ‘Collegium Pharmaceutical, Inc. - Product Pipeline Review - 2014’, provides an overview of the Collegium Pharmaceutical, Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Collegium Pharmaceutical, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $1500
Trino Therapeutics Ltd - Product Pipeline Review - 2014
Global Markets Direct’s, ‘Trino Therapeutics Ltd - Product Pipeline Review - 2014’, provides an overview of the Trino Therapeutics Ltd’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Trino Therapeutics Ltd’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $1500
Alzheimers Disease - Pipeline Review, H1 2014
Global Markets Direct’s, ‘Alzheimer's Disease - Pipeline Review, H1 2014’, provides an overview of the Alzheimer's Disease’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Alzheimer's Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Alzheimer's Disease and special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2500
Type 2 Diabetes - Pipeline Review, H1 2014
Global Markets Direct’s, ‘Type 2 Diabetes - Pipeline Review, H1 2014’, provides an overview of the Type 2 Diabetes’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Type 2 Diabetes, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Type 2 Diabetes and special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications.
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2500
Parkinsons Disease - Pipeline Review, H1 2014
Global Markets Direct’s, ‘Parkinson's Disease - Pipeline Review, H1 2014’, provides an overview of the Parkinson's Disease’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Parkinson's Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Parkinson's Disease and special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2500
Hepatitis C - Pipeline Review, H1 2014
Global Markets Direct’s, ‘Hepatitis C - Pipeline Review, H1 2014’, provides an overview of the Hepatitis C’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hepatitis C, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hepatitis C and special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is bu
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2500
Colon Cancer - Pipeline Review, H1 2014
Global Markets Direct’s, ‘Colon Cancer - Pipeline Review, H1 2014’, provides an overview of the Colon Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Colon Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Colon Cancer and special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report i
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Psoriasis - Pipeline Review, H1 2014
Global Markets Direct’s, ‘Psoriasis - Pipeline Review, H1 2014’, provides an overview of the Psoriasis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Psoriasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Psoriasis and special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built usin
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Schizophrenia - Pipeline Review, H1 2014
Global Markets Direct’s, ‘Schizophrenia - Pipeline Review, H1 2014’, provides an overview of the Schizophrenia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Schizophrenia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Schizophrenia and special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The repo
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Osteoarthritis Pain - Pipeline Review, H1 2014
Global Markets Direct’s, ‘Osteoarthritis Pain - Pipeline Review, H1 2014’, provides an overview of the Osteoarthritis Pain’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Osteoarthritis Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Osteoarthritis Pain and special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,0
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2014
Global Markets Direct’s, ‘Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2014’, provides an overview of the Cytomegalovirus (HHV-5) Infections’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cytomegalovirus (HHV-5) Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cytomegalovirus (HHV-5) Infections and special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs fro
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Major Depressive Disorder - Pipeline Review, H1 2014
Global Markets Direct’s, ‘Major Depressive Disorder - Pipeline Review, H1 2014’, provides an overview of the Major Depressive Disorder’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Major Depressive Disorder, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Major Depressive Disorder and special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 ther
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2014
Global Markets Direct’s, ‘Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2014’, provides an overview of the Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Met
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Refractory Multiple Myeloma - Pipeline Review, H1 2014
Global Markets Direct’s, ‘Refractory Multiple Myeloma - Pipeline Review, H1 2014’, provides an overview of the Refractory Multiple Myeloma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Refractory Multiple Myeloma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Refractory Multiple Myeloma and special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Mantle Cell Lymphoma - Pipeline Review, H1 2014
Global Markets Direct’s, ‘Mantle Cell Lymphoma - Pipeline Review, H1 2014’, provides an overview of the Mantle Cell Lymphoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Mantle Cell Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Mantle Cell Lymphoma and special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2014
Global Markets Direct’s, ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2014’, provides an overview of the B-Cell Non-Hodgkin Lymphoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for B-Cell Non-Hodgkin Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for B-Cell Non-Hodgkin Lymphoma and special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Drug Addiction - Pipeline Review, H1 2014
Global Markets Direct’s, ‘Drug Addiction - Pipeline Review, H1 2014’, provides an overview of the Drug Addiction’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Drug Addiction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Drug Addiction and special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Hodgkin Lymphoma - Pipeline Review, H1 2014
Global Markets Direct’s, ‘Hodgkin Lymphoma - Pipeline Review, H1 2014’, provides an overview of the Hodgkin Lymphoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hodgkin Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hodgkin Lymphoma and special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indic
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Peritoneal Cancer - Pipeline Review, H1 2014
Global Markets Direct’s, ‘Peritoneal Cancer - Pipeline Review, H1 2014’, provides an overview of the Peritoneal Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Peritoneal Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Peritoneal Cancer and special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indic
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2014
Global Markets Direct’s, ‘Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2014’, provides an overview of the Metastatic Renal Cell Carcinoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Metastatic Renal Cell Carcinoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Metastatic Renal Cell Carcinoma and special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across glo
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Rheumatoid Arthritis - Pipeline Review, H1 2014
Rheumatoid Arthritis - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Rheumatoid Arthritis - Pipeline Review, H1 2014, provides an overview of the Rheumatoid Arthritiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Rheumatoid Arthritis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Rheumatoid Arthritis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2500
Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2014
Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2014, provides an overview of the Chronic Obstructive Pulmonary Disease (COPD)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Chronic Obstructive Pulmonary Disease (COPD), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chronic Obstructive Pulmonary Disease (COPD) and special features on late-stage and discontinue
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2014
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2014, provides an overview of the Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Acute Myelocytic Leukemia (AML,
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Neuropathic Pain - Pipeline Review, H1 2014
Neuropathic Pain - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Neuropathic Pain - Pipeline Review, H1 2014, provides an overview of the Neuropathic Pains therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Neuropathic Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Neuropathic Pain and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 in
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2014
Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2014, provides an overview of the Amyotrophic Lateral Sclerosiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Amyotrophic Lateral Sclerosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Amyotrophic Lateral Sclerosis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs fro
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Tuberculosis - Pipeline Review, H1 2014
Tuberculosis - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Tuberculosis - Pipeline Review, H1 2014, provides an overview of the Tuberculosiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Tuberculosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Tuberculosis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The repor
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Stroke - Pipeline Review, H1 2014
Stroke - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Stroke - Pipeline Review, H1 2014, provides an overview of the Strokes therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Stroke, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Stroke and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and info
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
HIV-1 Infection - Pipeline Review, H1 2014
HIV-1 Infection - Pipeline Review, H1 2014SummaryGlobal Markets Directs, HIV-1 Infection - Pipeline Review, H1 2014, provides an overview of the HIV-1 Infections therapeutic pipeline.This report provides comprehensive information on the therapeutic development for HIV-1 Infection, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for HIV-1 Infection and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indicat
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Atherosclerosis - Pipeline Review, H1 2014
Atherosclerosis - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Atherosclerosis - Pipeline Review, H1 2014, provides an overview of the Atherosclerosiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Atherosclerosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Atherosclerosis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indicat
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Crohns Disease - Pipeline Review, H1 2014
Crohn's Disease - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Crohn's Disease - Pipeline Review, H1 2014, provides an overview of the Crohn's Diseases therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Crohn's Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Crohn's Disease and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indicat
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Non-Hodgkin Lymphoma - Pipeline Review, H1 2014
Non-Hodgkin Lymphoma - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Non-Hodgkin Lymphoma - Pipeline Review, H1 2014, provides an overview of the Non-Hodgkin Lymphomas therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Non-Hodgkin Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Non-Hodgkin Lymphoma and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Myocardial Infarction - Pipeline Review, H1 2014
Myocardial Infarction - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Myocardial Infarction - Pipeline Review, H1 2014, provides an overview of the Myocardial Infarctions therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Myocardial Infarction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Myocardial Infarction and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Ulcerative Colitis - Pipeline Review, H1 2014
Ulcerative Colitis - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Ulcerative Colitis - Pipeline Review, H1 2014, provides an overview of the Ulcerative Colitiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Ulcerative Colitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ulcerative Colitis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearl
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2014
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2014, provides an overview of the Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Acute Lymphocytic Leuke
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Atopic Dermatitis - Pipeline Review, H1 2014
Atopic Dermatitis - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Atopic Dermatitis - Pipeline Review, H1 2014, provides an overview of the Atopic Dermatitiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Atopic Dermatitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Atopic Dermatitis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,0
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Hypertension - Pipeline Review, H1 2014
peline Review, H1 2014SummaryGlobal Markets Directs, Hypertension - Pipeline Review, H1 2014, provides an overview of the Hypertensions therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Hypertension, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hypertension and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Osteoporosis - Pipeline Review, H1 2014
Osteoporosis - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Osteoporosis - Pipeline Review, H1 2014, provides an overview of the Osteoporosiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Osteoporosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Osteoporosis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The repor
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Osteoarthritis - Pipeline Review, H1 2014
Osteoarthritis - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Osteoarthritis - Pipeline Review, H1 2014, provides an overview of the Osteoarthritiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Osteoarthritis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Osteoarthritis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications.
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Huntingtons Disease - Pipeline Review, H1 2014
Huntington's Disease - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Huntington's Disease - Pipeline Review, H1 2014, provides an overview of the Huntington's Diseases therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Huntington's Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Huntington's Disease and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Epilepsy - Pipeline Review, H1 2014
Epilepsy - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Epilepsy - Pipeline Review, H1 2014, provides an overview of the Epilepsys therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Epilepsy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Epilepsy and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using dat
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Cervical Cancer - Pipeline Review, H1 2014
Cervical Cancer - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Cervical Cancer - Pipeline Review, H1 2014, provides an overview of the Cervical Cancers therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Cervical Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cervical Cancer and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indicat
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Metastatic Colorectal Cancer - Pipeline Review, H1 2014
Metastatic Colorectal Cancer - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Metastatic Colorectal Cancer - Pipeline Review, H1 2014, provides an overview of the Metastatic Colorectal Cancers therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Metastatic Colorectal Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Metastatic Colorectal Cancer and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from acr
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Glaucoma - Pipeline Review, H1 2014
Glaucoma - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Glaucoma - Pipeline Review, H1 2014, provides an overview of the Glaucomas therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Glaucoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Glaucoma and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using dat
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2014
Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2014, provides an overview of the Respiratory Syncytial Virus (RSV) Infectionss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Respiratory Syncytial Virus (RSV) Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Respiratory Syncytial Virus (RSV) Infections and special features on late-stage and discontinue
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Systemic Lupus Erythematosus - Pipeline Review, H1 2014
Systemic Lupus Erythematosus - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Systemic Lupus Erythematosus - Pipeline Review, H1 2014, provides an overview of the Systemic Lupus Erythematosuss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Systemic Lupus Erythematosus, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Systemic Lupus Erythematosus and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from acr
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Small-Cell Lung Cancer - Pipeline Review, H1 2014
Small-Cell Lung Cancer - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Small-Cell Lung Cancer - Pipeline Review, H1 2014, provides an overview of the Small-Cell Lung Cancers therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Small-Cell Lung Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Small-Cell Lung Cancer and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 the
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Myelodysplastic Syndrome - Pipeline Review, H1 2014
Myelodysplastic Syndrome - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Myelodysplastic Syndrome - Pipeline Review, H1 2014, provides an overview of the Myelodysplastic Syndromes therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Myelodysplastic Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Myelodysplastic Syndrome and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering o
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Neuroblastoma - Pipeline Review, H1 2014
Neuroblastoma - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Neuroblastoma - Pipeline Review, H1 2014, provides an overview of the Neuroblastomas therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Neuroblastoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Neuroblastoma and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Arthritis - Pipeline Review, H1 2014
Arthritis - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Arthritis - Pipeline Review, H1 2014, provides an overview of the Arthritiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Arthritis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Arthritis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built usin
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Dyslipidemia - Pipeline Review, H1 2014
Dyslipidemia - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Dyslipidemia - Pipeline Review, H1 2014, provides an overview of the Dyslipidemias therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Dyslipidemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Dyslipidemia and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The repor
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Inflammatory Pain - Pipeline Review, H1 2014
Inflammatory Pain - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Inflammatory Pain - Pipeline Review, H1 2014, provides an overview of the Inflammatory Pains therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Inflammatory Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Inflammatory Pain and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,0
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Spinal Cord Injury - Pipeline Review, H1 2014
Spinal Cord Injury - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Spinal Cord Injury - Pipeline Review, H1 2014, provides an overview of the Spinal Cord Injurys therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Spinal Cord Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Spinal Cord Injury and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearl
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Duchenne Muscular Dystrophy - Pipeline Review, H1 2014
Duchenne Muscular Dystrophy - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Duchenne Muscular Dystrophy - Pipeline Review, H1 2014, provides an overview of the Duchenne Muscular Dystrophys therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Duchenne Muscular Dystrophy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Duchenne Muscular Dystrophy and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across g
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2014
Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2014, provides an overview of the Diffuse Large B-Cell Lymphomas therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Diffuse Large B-Cell Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Diffuse Large B-Cell Lymphoma and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs fro
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2014
Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2014, provides an overview of the Plaque Psoriasis (Psoriasis Vulgaris)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Plaque Psoriasis (Psoriasis Vulgaris), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Plaque Psoriasis (Psoriasis Vulgaris) and special features on late-stage and discontinued projects.Global Markets Directs r
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Migraine - Pipeline Review, H1 2014
Migraine - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Migraine - Pipeline Review, H1 2014, provides an overview of the Migraines therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Migraine, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Migraine and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using dat
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Bladder Cancer - Pipeline Review, H1 2014
Bladder Cancer - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Bladder Cancer - Pipeline Review, H1 2014, provides an overview of the Bladder Cancers therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Bladder Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Bladder Cancer and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications.
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Acute Pain - Pipeline Review, H1 2014
Acute Pain - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Acute Pain - Pipeline Review, H1 2014, provides an overview of the Acute Pains therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Acute Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Acute Pain and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Hemophilia A - Pipeline Review, H1 2014
Hemophilia A - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Hemophilia A - Pipeline Review, H1 2014, provides an overview of the Hemophilia As therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Hemophilia A, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hemophilia A and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The repor
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Allergic Rhinitis - Pipeline Review, H1 2014
Allergic Rhinitis - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Allergic Rhinitis - Pipeline Review, H1 2014, provides an overview of the Allergic Rhinitiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Allergic Rhinitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Allergic Rhinitis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,0
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Pandemic Influenza - Pipeline Review, H1 2014
Pandemic Influenza - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Pandemic Influenza - Pipeline Review, H1 2014, provides an overview of the Pandemic Influenzas therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Pandemic Influenza, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pandemic Influenza and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearl
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H1 2014
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H1 2014, provides an overview of the Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Radiation T
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Seasonal Influenza - Pipeline Review, H1 2014
Seasonal Influenza - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Seasonal Influenza - Pipeline Review, H1 2014, provides an overview of the Seasonal Influenzas therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Seasonal Influenza, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Seasonal Influenza and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearl
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Metastatic Pancreatic Cancer - Pipeline Review, H1 2014
Metastatic Pancreatic Cancer - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Metastatic Pancreatic Cancer - Pipeline Review, H1 2014, provides an overview of the Metastatic Pancreatic Cancers therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Metastatic Pancreatic Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Metastatic Pancreatic Cancer and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from acr
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Ankylosing Spondylitis (Bekhterevs Disease) - Pipeline Review, H1 2014
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2014, provides an overview of the Ankylosing Spondylitis (Bekhterev's Disease)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Ankylosing Spondylitis (Bekhterev's Disease), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ankylosing Spondylitis (Bekhterev's Disease) and special features on late-stage and discontinue
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Endometrial Cancer - Pipeline Review, H1 2014
Endometrial Cancer - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Endometrial Cancer - Pipeline Review, H1 2014, provides an overview of the Endometrial Cancers therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Endometrial Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Endometrial Cancer and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearl
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Women Infertility - Pipeline Review, H1 2014
Women Infertility - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Women Infertility - Pipeline Review, H1 2014, provides an overview of the Women Infertilitys therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Women Infertility, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Women Infertility and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,0
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Substance (Drug) Abuse - Pipeline Review, H1 2014
Substance (Drug) Abuse - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Substance (Drug) Abuse - Pipeline Review, H1 2014, provides an overview of the Substance (Drug) Abuses therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Substance (Drug) Abuse, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Substance (Drug) Abuse and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 the
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Brain Cancer - Pipeline Review, H1 2014
l Markets Directs, Brain Cancer - Pipeline Review, H1 2014, provides an overview of the Brain Cancers therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Brain Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Brain Cancer and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Fallopian Tube Cancer - Pipeline Review, H1 2014
Fallopian Tube Cancer - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Fallopian Tube Cancer - Pipeline Review, H1 2014, provides an overview of the Fallopian Tube Cancers therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Fallopian Tube Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Fallopian Tube Cancer and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Follicular Lymphoma - Pipeline Review, H1 2014
Follicular Lymphoma - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Follicular Lymphoma - Pipeline Review, H1 2014, provides an overview of the Follicular Lymphomas therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Follicular Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Follicular Lymphoma and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Vancomycin-Resistant Enterococcus Faecium Infections - Pipeline Review, H1 2014
Vancomycin-Resistant Enterococcus Faecium Infections - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Vancomycin-Resistant Enterococcus Faecium Infections - Pipeline Review, H1 2014, provides an overview of the Vancomycin-Resistant Enterococcus Faecium Infectionss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Vancomycin-Resistant Enterococcus Faecium Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Vancomycin-Resistant Enterococcus Faecium Infections and specia
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2014
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2014, provides an overview of the Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Epithelial Ovarian Cancer - Pipeline Review, H1 2014
Epithelial Ovarian Cancer - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Epithelial Ovarian Cancer - Pipeline Review, H1 2014, provides an overview of the Epithelial Ovarian Cancers therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Epithelial Ovarian Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Epithelial Ovarian Cancer and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe cover
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2014
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2014, provides an overview of the Coronary Artery Disease (CAD) (Ischemic Heart Disease)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Coronary Artery Disease (CAD) (Ischemic Heart Disease), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Coronary Artery Disease (CAD) (Ischemic Heart Disease)
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Chronic Heart Failure - Pipeline Review, H1 2014
Chronic Heart Failure - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Chronic Heart Failure - Pipeline Review, H1 2014, provides an overview of the Chronic Heart Failures therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Chronic Heart Failure, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chronic Heart Failure and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Open-Angle Glaucoma - Pipeline Review, H1 2014
Open-Angle Glaucoma - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Open-Angle Glaucoma - Pipeline Review, H1 2014, provides an overview of the Open-Angle Glaucomas therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Open-Angle Glaucoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Open-Angle Glaucoma and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2014
Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2014, provides an overview of the Gastrointestinal Stromal Tumor (GIST)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Gastrointestinal Stromal Tumor (GIST), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Gastrointestinal Stromal Tumor (GIST) and special features on late-stage and discontinued projects.Global Markets Directs r
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Brain Tumor - Pipeline Review, H1 2014
Brain Tumor - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Brain Tumor - Pipeline Review, H1 2014, provides an overview of the Brain Tumors therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Brain Tumor, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Brain Tumor and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Malignant Mesothelioma - Pipeline Review, H1 2014
Malignant Mesothelioma - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Malignant Mesothelioma - Pipeline Review, H1 2014, provides an overview of the Malignant Mesotheliomas therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Malignant Mesothelioma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Malignant Mesothelioma and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 the
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Myocardial Ischemia - Pipeline Review, H1 2014
Myocardial Ischemia - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Myocardial Ischemia - Pipeline Review, H1 2014, provides an overview of the Myocardial Ischemias therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Myocardial Ischemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Myocardial Ischemia and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Malignant Pleural Mesothelioma - Pipeline Review, H1 2014
Mesothelioma - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Malignant Pleural Mesothelioma - Pipeline Review, H1 2014, provides an overview of the Malignant Pleural Mesotheliomas therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Malignant Pleural Mesothelioma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Malignant Pleural Mesothelioma and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across glob
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Helicobacter Pylori Infections - Pipeline Review, H1 2014
Helicobacter Pylori Infections - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Helicobacter Pylori Infections - Pipeline Review, H1 2014, provides an overview of the Helicobacter Pylori Infectionss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Helicobacter Pylori Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Helicobacter Pylori Infections and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drug
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Nasopharyngeal Cancer - Pipeline Review, H1 2014
Nasopharyngeal Cancer - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Nasopharyngeal Cancer - Pipeline Review, H1 2014, provides an overview of the Nasopharyngeal Cancers therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Nasopharyngeal Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Nasopharyngeal Cancer and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H1 2014
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H1 2014, provides an overview of the Non Alcoholic Fatty Liver Disease (NAFLD)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Non Alcoholic Fatty Liver Disease (NAFLD), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Non Alcoholic Fatty Liver Disease (NAFLD) and special features on late-stage and discontinued projects.Glob
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Brain Metastasis - Pipeline Review, H1 2014
Brain Metastasis - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Brain Metastasis - Pipeline Review, H1 2014, provides an overview of the Brain Metastasiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Brain Metastasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Brain Metastasis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 in
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Kidney Fibrosis - Pipeline Review, H1 2014
Kidney Fibrosis - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Kidney Fibrosis - Pipeline Review, H1 2014, provides an overview of the Kidney Fibrosiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Kidney Fibrosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Kidney Fibrosis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indicat
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Angina (Angina Pectoris) - Pipeline Review, H1 2014
2014SummaryGlobal Markets Directs, Angina (Angina Pectoris) - Pipeline Review, H1 2014, provides an overview of the Angina (Angina Pectoris)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Angina (Angina Pectoris), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Angina (Angina Pectoris) and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indicatio
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2014
umonia (VAP) - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2014, provides an overview of the Ventilator Associated Pneumonia (VAP)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Ventilator Associated Pneumonia (VAP), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ventilator Associated Pneumonia (VAP) and special features on late-stage and discontinued projects.Global Markets Directs report features investigat
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Pulmonary Hypertension - Pipeline Review, H1 2014
Pulmonary Hypertension - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Pulmonary Hypertension - Pipeline Review, H1 2014, provides an overview of the Pulmonary Hypertensions therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Pulmonary Hypertension, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pulmonary Hypertension and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 the
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Psychosis - Pipeline Review, H1 2014
Psychosis - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Psychosis - Pipeline Review, H1 2014, provides an overview of the Psychosiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Psychosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Psychosis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built usin
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Measles - Pipeline Review, H1 2014
Measles - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Measles - Pipeline Review, H1 2014, provides an overview of the Measless therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Measles, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Measles and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2014
Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2014, provides an overview of the Relapsed Chronic Lymphocytic Leukemia (CLL)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Relapsed Chronic Lymphocytic Leukemia (CLL), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Relapsed Chronic Lymphocytic Leukemia (CLL) and special features on late-stage and discontinued pro
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Liver Failure - Pipeline Review, H1 2014
Liver Failure - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Liver Failure - Pipeline Review, H1 2014, provides an overview of the Liver Failures therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Liver Failure, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Liver Failure and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
T-Cell Leukemia - Pipeline Review, H1 2014
T-Cell Leukemia - Pipeline Review, H1 2014SummaryGlobal Markets Directs, T-Cell Leukemia - Pipeline Review, H1 2014, provides an overview of the T-Cell Leukemias therapeutic pipeline.This report provides comprehensive information on the therapeutic development for T-Cell Leukemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for T-Cell Leukemia and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indicat
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Ewing Sarcoma - Pipeline Review, H1 2014
Ewing Sarcoma - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Ewing Sarcoma - Pipeline Review, H1 2014, provides an overview of the Ewing Sarcomas therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Ewing Sarcoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ewing Sarcoma and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Neuro Endocrine (Carcinoid) Carcinoma - Pipeline Review, H1 2014
Neuro Endocrine (Carcinoid) Carcinoma - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Neuro Endocrine (Carcinoid) Carcinoma - Pipeline Review, H1 2014, provides an overview of the Neuro Endocrine (Carcinoid) Carcinomas therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Neuro Endocrine (Carcinoid) Carcinoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Neuro Endocrine (Carcinoid) Carcinoma and special features on late-stage and discontinued projects.Global Markets Directs r
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Rotavirus Infections - Pipeline Review, H1 2014
Rotavirus Infections - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Rotavirus Infections - Pipeline Review, H1 2014, provides an overview of the Rotavirus Infectionss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Rotavirus Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Rotavirus Infections and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000